Geller Biopharm Inc is a clinical-stage biopharmaceutical company focused on developing targeted therapies for cancer and other serious diseases. The company aims to advance innovative treatments that address unmet medical needs, leveraging its expertise in molecular biology and oncology to improve patient outcomes.